Low dose rapid scanning slit digital mammography and breast tomosynthesis
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA177093
- Recipient
-
Rapiscan Laboratories, Inc. UEI GHNUX5DL7AD5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,689,116
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Northridge, CA 91324, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $323,983 | |
| Amendment | -$356,615 | |
| Amendment | $0 | |
| Amendment | $816,615 | |
| Amendment | $680,133 | |
| Original award | $225,000 |
Quick answers
Who received award R44CA177093?
R44CA177093 was awarded to Rapiscan Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2014.
How much is award R44CA177093 worth?
$1,689,116 has been obligated on R44CA177093.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award